An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Clinical trial NCT00219232 · COMPLETED
Trial details
- NCT number
- NCT00219232
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2006-07-01
- Enrollment
- 868
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.